Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor...

Por Weller, C, O'Neill, C J, Charlett, A, Bowes, S G, Purkiss, A, Nicholson, P W, Dobbs, R J, Dobbs, S M
Publicado em 1993

Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients.

Por O'Neill, C J, Charlett, A, Dobbs, R J, Deshmukh, A A, Bowes, S G, Weller, C, Nicholson, P W, Milledge, J S, Dobbs, S M
Publicado em 1992

Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy?

Por Hughes, J R, Bowes, S G, Leeman, A L, O'Neill, C J, Deshmukh, A A, Nicholson, P W, Dobbs, S M, Dobbs, R J
Publicado em 1990

Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy.

Por Bowes, S G, Clark, P K, Leeman, A L, O'Neill, C J, Weller, C, Nicholson, P W, Deshmukh, A A, Dobbs, S M, Dobbs, R J
Publicado em 1990

Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.

Por Bowes, S G, Clark, P K, Charlett, A, O'Neill, C J, Leeman, A L, Weller, C, Nicholson, P W, Deshmukh, A A, Dobbs, S M, Dobbs, R J
Publicado em 1991

Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism

Por KIROLLOS, C., CHARLETT, A., O'NEILL, C. J. A., KOSIK, R., MOZOL, K., PURKISS, A. G., BOWES, S. G., NICHOLSON, P. W., HUNT, W. B., WELLER, C., DOBBS, S. M., DOBBS, R. J.
Publicado em 1996